Astera Labs, INC Form 4 insider transactions

Astera Labs' Chief Financial Officer, Michael Truett Tate, sold a significant number of shares through a pre-arranged 10b5-1 trading plan.

Astera Labs CEO Jitendra Mohan reported a gift of 12,600 common shares to a charitable entity and clarified beneficial ownership of shares held in various trusts.

Director Michael Hurlston of Astera Labs sold a total of 67,548 shares of common stock on November 27, 2024, under a pre-arranged 10b5-1 trading plan.

Astera Labs CEO, Jitendra Mohan, sold a total of 173,366 shares of common stock on November 25, 2024, through a pre-arranged trading plan.

A director at Astera Labs, Inc. has sold a significant number of shares in multiple transactions, according to a recent SEC filing.

Astera Labs CEO Jitendra Mohan sold 200,000 shares of common stock on November 21, 2024, at an average price of $103.5347 per share, under a pre-arranged 10b5-1 trading plan.

Astera Labs' General Counsel, Philip Mazzara, sold 2,513 shares of common stock to cover tax obligations related to vesting restricted stock units.

Astera Labs' Chief Financial Officer, Michael Truett Tate, sold 7,398 shares of common stock to cover tax obligations related to vesting restricted stock units.

Stefan A. Dyckerhoff, a director at Astera Labs, sold a significant number of shares in multiple transactions, both directly and indirectly, on November 18th and 19th, 2024.

Director Jack R. Lazar of Astera Labs sold a total of 12,500 shares of common stock on November 15, 2024, under a pre-arranged 10b5-1 trading plan.

Astera Labs' General Counsel, Philip Mazzara, acquired 694 shares of common stock through the company's Employee Stock Purchase Plan at a price of $30.6 per share.

Astera Labs' Chief Financial Officer, Michael Tate, acquired 694 shares of common stock through the company's Employee Stock Purchase Plan.

Stefan A. Dyckerhoff, a director at Astera Labs, sold a total of 50,000 shares of common stock in multiple transactions on November 11, 2024.

Astera Labs CEO Jitendra Mohan sold a total of 2,304 shares of common stock at a weighted average price of $100.0079 per share, under a pre-arranged 10b5-1 trading plan.

Director Manuel Alba of Astera Labs sold shares of the company's common stock on November 7th and 8th, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc. (ALAB), sold shares of common stock on November 7 and 8, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Sanjay Gajendra, President and COO of Astera Labs, sold shares of common stock on November 7, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Stefan A. Dyckerhoff of Astera Labs, Inc. reports the sale of common stock in multiple transactions on November 6, 2024.

Astera Labs CEO Jitendra Mohan sold 70,631 shares of common stock at a weighted average price of $91.9363 on November 6, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Sanjay Gajendra, President and COO of Astera Labs, sold a total of 110,000 shares of common stock on October 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs CEO Jitendra Mohan sold shares of the company's common stock on October 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Jack R. Lazar of Astera Labs, Inc. sold 2,000 shares of common stock at a price of $69.95 per share on October 11, 2024, according to a Form 4 filing.

Director Jack R. Lazar of Astera Labs, Inc. executed a sale of 3,000 shares of common stock at a price of $61.69 per share on October 9, 2024, under a pre-arranged 10b5-1 trading plan.

Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc., sold a portion of his common stock holdings on October 9, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Michael Tate, CFO of Astera Labs, sold 100,000 shares of common stock on October 9, 2024, at a weighted average price of $62.0336, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Director Stefan A. Dyckerhoff reports changes in beneficial ownership of Astera Labs, Inc. stock due to an in-kind distribution and acquisitions by various trusts and entities.

Chief Financial Officer Michael Truett Tate transferred 1,033,780 shares of Astera Labs common stock to the Tate Trust on October 2, 2024.

Astera Labs CEO Jitendra Mohan sold shares of the company's common stock on October 1, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Director Stefan A. Dyckerhoff reports a gift of Astera Labs shares and details of indirect beneficial ownership through various entities.

Director Jack R. Lazar sold shares of Astera Labs, Inc. (ALAB) on September 23, 2024, under a pre-arranged Rule 10b5-1 trading plan.